Literature DB >> 26472415

A Study of Multiple Causes of Death in Rheumatoid Arthritis.

Frederico A G Pinheiro1, Deborah C C Souza1, Emilia I Sato2.   

Abstract

OBJECTIVE: To evaluate rheumatoid arthritis (RA)-related mortality in the state of São Paulo (Brazil).
METHODS: Data from all death certificates (DC) from 1996 to 2010 were analyzed using a multiple cause-of-death method. We compared the results from 2 subperiods (1996-2000 and 2006-2010).
RESULTS: We found 3955 DC related to RA - 27.6% with RA as the underlying cause of death (UCD) and 72.4% with RA as the nonunderlying cause of death (NUCD). Ninety percent of RA-related deaths occurred at age ≥ 50 years. The mean ages at death were 67.1 ± 13.3 and 67.9 ± 13 years for RA as the UCD and NUCD, respectively. The most frequent NUCD associated with RA were pneumonia, sepsis, renal failure, interstitial lung disease, and heart failure. In the last subperiod, there was an increase in infectious causes. When RA was an NUCD, we observed a decrease in the mean age at death for the last subperiod (p = 0.021). The most common UCD were circulatory and respiratory system diseases. Comparing the mean age at death between RA-related deaths and the general population when deaths occurred at ages beyond 50 years, the linear regression analysis showed a downward curve for RA-related death (p < 0.001 and r = -0.795), while for the general population, as expected, the curve had an upward pattern (p < 0.001 and r = 0.993).
CONCLUSION: Unexpectedly, RA-related deaths occurred at earlier ages in the more recent subperiod. Cardiovascular disease remained the most important cause, and infectious diseases are an increasing cause of death associated with RA, raising the question of whether infections were related to the more vigorous immunosuppressive treatment recommended by recent guidelines.

Entities:  

Keywords:  BRAZIL; CAUSES OF DEATH; MORTALITY; RHEUMATOID ARTHRITIS; VITAL STATISTICS

Mesh:

Year:  2015        PMID: 26472415     DOI: 10.3899/jrheum.150166

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  9 in total

1.  Risk of hospitalization for heart failure in rheumatoid arthritis patients treated with etanercept and abatacept.

Authors:  Elena Generali; Greta Carrara; Marinos Kallikourdis; Gianluigi Condorelli; Alessandra Bortoluzzi; Carlo A Scirè; Carlo Selmi
Journal:  Rheumatol Int       Date:  2018-11-10       Impact factor: 2.631

2.  Changing rate of serious infections in biologic-exposed rheumatoid arthritis patients. Data from South American registries BIOBADABRASIL and BIOBADASAR.

Authors:  Roberto Ranza; Maria Celina de la Vega; Ieda Maria Magalhães Laurindo; Marìa Gimena Gómez; David Cezar Titton; Adriana Maria Kakehasi; Alejandro Brigante; Alejandro Benitez; Aline Ranzolin; Amelia Granel; Ana María Cappuccio; Ana Quinteros; André Luiz Shinji Hayata; Andrea Smichowski; Ângela Luzia Branco P Duarte; Barbara Stadler Kahlow; Carolina Sánchez Andia; Claiton Viegas Brenol; Edson Velozo; Eduardo Mussano; Enrique R Soriano; Georges Basile Christopoulos; Geraldo da Rocha Castelar Pinheiro; Gláucio Ricardo Werner de Castro; Gustavo Casado; Hellen Mary da Silveira Carvalho; Ida Elena Exeni; Inês Guimarães da Silveira; Ingrid Petkovic; Ivanio Alves Pereira; Izaias Pereira da Costa; Javier Eduardo Rosa; José Roberto Silva Miranda; Julio Cesar Bertacini de Moraes; Manoel Barros Bertolo; Manuel Buhl; Maria Alícia Lázaro; Maria de Fátima Lobato C da Sauma; Marcelo de Medeiros Pinheiro; Monica Díaz; Mônica Valéria Siqueira Santana de Vechi; Osvaldo Luis Cerda; Pablo Astesana; Pablo Finucci Curi; Paulo Louzada-Jr; Reginaldo Botelho Teodoro; Roberto Acayaba Toledo; Sílvia Papasidero; Valeria Valim; Vander Fernandes; Veronica Saurit; Washington Alves Bianchi; Rogério de Melo Costa Pinto; Miguel Angel Descalzo; Juan Jesus Gomez-Reino
Journal:  Clin Rheumatol       Date:  2019-04-17       Impact factor: 2.980

3.  Changing trends in rheumatoid arthritis mortality in Mexico, from 1998 to 2017.

Authors:  Ivet Morales-Etchegaray; Mario Garcia-Carrasco; Pamela Munguía-Realpozo; Claudia Mendoza-Pinto; Socorro Méndez-Martínez; Olivia Navarro-Milán; Sandra Karina Velez-Pelcastre; Carlos Javier Pineda-Villaseñor
Journal:  Rheumatol Int       Date:  2021-10-05       Impact factor: 2.631

4.  Rheumatoid arthritis T cell and muscle oxidative metabolism associate with exercise-induced changes in cardiorespiratory fitness.

Authors:  David B Bartlett; Kim M Huffman; Brian J Andonian; Alec Koss; Timothy R Koves; Elizabeth R Hauser; Monica J Hubal; David M Pober; Janet M Lord; Nancie J MacIver; E William St Clair; Deborah M Muoio; William E Kraus
Journal:  Sci Rep       Date:  2022-05-06       Impact factor: 4.996

Review 5.  Clinical, Epidemiological, and Histopathological Features of Respiratory Involvement in Rheumatoid Arthritis.

Authors:  Alessia Alunno; Roberto Gerli; Roberto Giacomelli; Francesco Carubbi
Journal:  Biomed Res Int       Date:  2017-11-07       Impact factor: 3.411

6.  Patients with Rheumatoid Arthritis Show Altered Lipoprotein Profiles with Dysfunctional High-Density Lipoproteins that Can Exacerbate Inflammatory and Atherogenic Process.

Authors:  Jae-Yong Kim; Eun-Young Lee; Jin Kyun Park; Yeong Wook Song; Jae-Ryong Kim; Kyung-Hyun Cho
Journal:  PLoS One       Date:  2016-10-13       Impact factor: 3.240

7.  Influence factors of extra-articular manifestations in rheumatoid arthritis.

Authors:  Xing Chen; Mingmei Zhang; Tao Wang; Yunming Li; Meng Wei
Journal:  Open Med (Wars)       Date:  2020-08-26

Review 8.  Nailfold Videocapillaroscopy for the Evaluation of Peripheral Microangiopathy in Rheumatoid Arthritis.

Authors:  Panagiota Anyfanti; Elena Angeloudi; Athanasia Dara; Alexandra Arvanitaki; Eleni Bekiari; George D Kitas; Theodoros Dimitroulas
Journal:  Life (Basel)       Date:  2022-07-31

9.  Multicenter Cross-sectional Study of Patients with Rheumatoid Arthritis in Greece: Results from a cohort of 2.491 patients.

Authors:  Konstantinos Thomas; Argiro Lazarini; Evripidis Kaltsonoudis; Alexandros Drosos; Ioannis Papalopoulos; Prodromos Sidiropoulos; Pelagia Katsimbri; Dimitrios Boumpas; Panagiota Tsatsani; Sousana Gazi; Kalliopi Fragkiadaki; Maria Tektonidou; Petros P Sfikakis; Lina Pantazi; Kyriaki A Boki; Eleftheria P Grika; Panagiotis G Vlachoyiannopoulos; Konstantina Karagianni; Lazaros I Sakkas; Theodoros Dimitroulas; Alexandros Garyfallos; Dimitrios Kassimos; Gerasimos Evangelatos; Alexios Iliopoulos; Maria Areti; Constantinos Georganas; Konstantinos Melissaropoulos; Panagiotis Georgiou; Periklis Vounotrypidis; Konstantinos Ntelis; Clio P Mavragani; Ilias Bournazos; Gikas Katsifis; Christos Mavrommatis; George D Kitas; Dimitrios Vassilopoulos
Journal:  Mediterr J Rheumatol       Date:  2018-03-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.